Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Landec Corporation (LNDC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.06-0.11 (-1.20%)
At close: 04:00PM EDT
9.06 0.00 (0.00%)
After hours: 04:00PM EDT
Advertisement

Landec Corporation

2811 Airpark Drive
Santa Maria, CA 93455
United States
650 306 1650
https://www.landec.com

Sector(s)Consumer Defensive
IndustryPackaged Foods
Full Time Employees905

Key Executives

NameTitlePayExercisedYear Born
Dr. Albert D. Bolles Ph.D.CEO, Pres & Director989.46kN/A1958
Mr. John D. MorbergCFO & Sec.472.37kN/A1964
Mr. James G. HallVP & Pres of Lifecore706.26kN/A1963
Mr. Aaron PerlitshDirector of Internal Audit & Chief Compliance OfficerN/AN/AN/A
Mr. Parker K. JavidVPN/AN/A1970
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Landec Corporation, together with its subsidiaries, engages in the design, development, manufacture, and sale of differentiated health and wellness products for food and biomaterials markets. It operates through Curation Foods and Lifecore segments. The Curation Foods segment engages in processing, marketing, and selling of plant-based salads, and fresh-cut and whole processed vegetables primarily under the Eat Smart brand, O branded olive oils and wine vinegars, and Yucatan and Cabo Fresh guacamole and avocado food products, as well as various private labels to retail grocery chains, club stores, and food service operators; and sells BreatheWay packaging products. The Lifecore segment manufactures pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products to treat various medical conditions and procedures. It also provides product development services, including technology transfer, material component changes, analytical method and formulation development, pilot and stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. It operates in the United States, Canada, Belgium, Switzerland, Czech Republic, Ireland, and internationally. The company was incorporated in 1986 and is headquartered in Santa Maria, California.

Corporate Governance

Landec Corporation’s ISS Governance QualityScore as of May 1, 2022 is 2. The pillar scores are Audit: 6; Board: 3; Shareholder Rights: 1; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement